BIOVENTUS INC - A (BVS) Stock Balance Sheet
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
| MRQ (2024-9-28) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 43.07M | 36.96M | 31.80M | 43.90M | 86.80M | |||
| Receivables | 121.92M | 123.05M | 136.90M | 125.00M | 88.40M | |||
| Inventories | 90.03M | 91.33M | 85.40M | 61.70M | 29.10M | |||
| Other Current Assets | 43.66M | 16.66M | 18.40M | 32.50M | 7.50M | |||
| Total Current Assets | 298.69M | 268.00M | 272.60M | 263.10M | 211.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 39.20M | 49.96M | 45.00M | 40.20M | 21.80M | |||
| Investments And Advances | 1.93M | 3.14M | 2.60M | 29.30M | 19.40M | |||
| Goodwill | 7.46M | 7.46M | 13.80M | 147.60M | 49.80M | |||
| Intangibles | 414.81M | 482.35M | 1.04B | 695.20M | 191.70M | |||
| Other Non-Current Assets | 7.40M | 0.00 | 0.00 | 50.50M | N/A | |||
| Total Non-Current Assets | 470.80M | 542.91M | 1.10B | 962.80M | 282.70M | |||
| TOTAL ASSETS | 769.49M | 810.91M | 1.37B | 1.23B | 494.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 38.57M | 27.85M | 33.10M | 18.00M | 15.00M | |||
| Accrued Expenses | 125.66M | 119.10M | 113.10M | 137.70M | 98.80M | |||
| Accounts Payable | 16.85M | 23.04M | 37.50M | 16.90M | 4.40M | |||
| Other Current Liabilities | 30.41M | 5.51M | 120.30M | 8.20M | 4.40M | |||
| Total Current Liabilities | 211.49M | 175.50M | 304.00M | 180.90M | 122.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 345.02M | 367.00M | 385.00M | 339.60M | 173.40M | |||
| Deferred Taxes/Income | 0.00 | 1.21M | 154.00M | 133.50M | 3.40M | |||
| Other Non-Current Liabilities | 26.15M | 46.08M | 189.30M | 38.10M | 51.00M | |||
| Total Non-Current Liabilities | 409.26M | 461.82M | 752.10M | 586.00M | 229.60M | |||
| TOTAL LIABILITIES | 620.75M | 637.32M | 1.06B | 766.90M | 352.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -354.92M | -321.54M | -165.30M | -6.60M | -140.70M | |||
| Additional Paid In Capital | 503.13M | 494.25M | 481.90M | 465.30M | N/A | |||
| Minority Interest | 38.09M | 47.53M | 23.80M | 74.90M | 1.90M | |||
| Common Shares | 81.00K | 79.00K | 100.00K | 100.00K | 281.40M | |||
| Other Shareholders' Equity | 445.00K | 794.00K | -100.00K | 200.00K | 1.60M | |||
| Shares Outstanding | 81.12M | 79.05M | 77.80M | 75.30M | 55.60M | |||
| Tangible Book Value per Share | -3.37 | -4.00 | -9.46 | -5.10 | -4.81 | |||
| Total Shareholders' Equity | 148.74M | 173.59M | 316.60M | 458.90M | 142.20M | |||
| TOTAL LIABILITIES AND EQUITY | 769.49M | 810.91M | 1.37B | 1.23B | 494.50M | |||
| Statistics | ||||||||
| Debt/Equity | 2.32 | 2.11 | 1.22 | 0.74 | 1.22 | |||
| Current Ratio | 1.41 | 1.53 | 0.90 | 1.45 | 1.73 | |||
| Return On Assets (ROA) | -5.13% | -19.27% | -11.56% | 1.58% | 0.89% | |||
| Return On Equity (ROE) | -26.54% | -90.00% | -50.13% | 4.23% | 3.09% | |||
| Return On Invested Capital (ROIC) | 2.30% | 0.16% | N/A | 1.53% | 5.82% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 2.49% | 0.17% | N/A | 1.59% | 7.59% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 13.83% | 0.95% | N/A | 10.08% | 49.65% | |||
All data in USD , ROIC based on taxRate of 0.21